Verrica Pharmaceuticals Newsroom

H.C. Wainwright Downgrades Verrica Pharmaceuticals(VRCA.US) to Hold Rating

Futu NewsNov 6 19:33

Verrica Downgraded to Sector Perform by RBC Capital

Seeking AlphaNov 6 05:34

TD Cowen Maintains Verrica Pharmaceuticals(VRCA.US) With Buy Rating, Cuts Target Price to $5

Futu NewsNov 6 01:33

Verrica Pharmaceuticals Cut to Sector Perform From Outperform by RBC Capital

Dow JonesNov 6 00:01

Verrica Pharmaceuticals Analyst Ratings

BenzingaNov 5 23:50

Hold Rating on Verrica Pharmaceuticals Amidst Restructuring and Financial Uncertainty

TipRanksNov 5 22:32

Needham Maintains Verrica Pharmaceuticals(VRCA.US) With Hold Rating

Futu NewsNov 5 22:31

RBC Capital Downgrades Verrica Pharmaceuticals(VRCA.US) to Hold Rating, Cuts Target Price to $2

Futu NewsNov 5 18:33

Verrica Pharmaceuticals Analyst Ratings

BenzingaOct 22 01:12

Verrica Pharmaceuticals Is Maintained at Outperform by RBC Capital

Dow JonesOct 5 00:06

RBC Lowers Price Target on Verrica Pharmaceuticals to $11 From $13, Keeps Outperform, Speculative Risk

MT NewswiresOct 4 19:39

Verrica Pharmaceuticals Price Target Maintained With a $12.00/Share by Needham

Dow JonesOct 3 17:44

Needham Downgrades Verrica Pharmaceuticals(VRCA.US) to Hold Rating

Futu NewsOct 3 03:31

Verrica Pharmaceuticals Analyst Ratings

BenzingaOct 3 00:48

Brookline Capital Downgrades Verrica Pharmaceuticals(VRCA.US) to Hold Rating

Futu NewsOct 2 23:32

RBC Adjusts Price Target on Verrica Pharmaceuticals to $13 From $14, Maintains Outperform

MT NewswiresAug 15 20:38

Analysts Conflicted on These Healthcare Names: Verrica Pharmaceuticals (VRCA), Celcuity (CELC) and Bluebird Bio (BLUE)

TipRanksAug 15 18:33

RBC Capital Maintains Verrica Pharmaceuticals(VRCA.US) With Buy Rating, Cuts Target Price to $13

Futu NewsAug 15 18:31

Verrica Pharmaceuticals Analyst Ratings

BenzingaAug 15 17:30

Needham Maintains Verrica Pharmaceuticals(VRCA.US) With Buy Rating, Cuts Target Price to $12

Futu NewsAug 15 03:32